Androgens and Hair Growth
Androgens and Hair Growth
ABSTRACT: Hair’s importance in human communication means that abnormalities like excess hair
in hirsutism or hair loss in alopecia cause psychological distress. Androgens are the main regulator of
human hair follicles, changing small vellus follicles producing tiny, virtually invisible hairs into larger
intermediate and terminal follicles making bigger, pigmented hairs. The response to androgens varies
with the body site as it is specific to the hair follicle itself. Normally around puberty, androgens stimu-
late axillary and pubic hair in both sexes, plus the beard, etc. in men, while later they may also inhibit
scalp hair growth causing androgenetic alopecia. Androgens act within the follicle to alter the mesen-
chyme–epithelial cell interactions, changing the length of time the hair is growing, the dermal papilla
size and dermal papilla cell, keratinocyte and melanocyte activity. Greater understanding of the
mechanisms of androgen action in follicles should improve therapies for poorly controlled hair
disorders like hirsutism and alopecia.
314
Androgens and hair growth
people who have never sought medical help (12). loss) (14). Whether the high incidence of androge-
These include both excessive hair growth, such as netic alopecia indicates a natural phenomenon,
hirsutism, or drug-induced abnormal hair growth, that is, a secondary sexual characteristic, rather
and hair loss, such as alopecia areata, an auto- than a disorder can be debated (1), but in the
immune disease affecting both sexes (13) or even current youth-oriented culture, looking older is
androgenetic alopecia (common male-pattern hair not beneficial.
315
Randall
316
Androgens and hair growth
FIG. 2. Androgens have paradoxically different effects on human hair follicles depending on their body site.
During, and after, puberty androgens stimulate the gradual transformation of small follicles producing tiny, virtually colorless,
vellus hairs to terminal follicles producing longer, thicker and more pigmented hairs (upper panel) (19). These changes involve
passing through the hair cycle (see FIG. 3). At the same time many follicles on the scalp and eyelashes continue to produce the
same type of hairs, apparently unaffected by androgens (middle panel). In complete contrast, androgens may inhibit follicles
on specific areas of the scalp in genetically susceptible individuals causing the reverse transformation of terminal follicles to
vellus ones and androgenetic alopecia (20). Diagram reproduced from Randall 2000 (132).
317
Randall
contains both the epithelial (28,29) and melano- which grows back down into the dermis, inside
cyte stem cells (30) in its permanent mid-region the guidelines of the dermal sheath which sur-
and becomes continuous with the epidermis at rounded the previous follicle. The new hair then
the skin surface. The connective tissue, or dermal, grows up into the original upper follicle (FIG. 3).
sheath encloses the follicle, separating it from the The existing hair is generally lost; although previ-
dermis. The dermal papilla produces paracrine ously thought due to the new hair’s upward move-
factors determining the size and color of the hair ment (24), a further active shedding stage, exogen,
produced (26,27,31); it is also believed to interpret involving the activation of proteolytic processes
circulating signals such as hormones for the has now been identified (42–44).
follicle (1,21) (discussed in 5). Although the cell
biology and biochemistry of hair growth are not
Significance of the hair cycle for hair length
fully clarified, factors implicated in anagen so far
include insulin-like growth factor-I (IGF-I) (32), The length of the hair cycle stages varies dramati-
keratinocyte growth factor (KGF) (33), hepatocyte cally in different parts of the human body (45).
growth factor (HGF) (34), noggin, and bone Scalp follicles have the longest anagen phases,
morphogenic protein (BMP)/Wnt5a (35) (reviewed which can last up to several years; waist length
in (36–38)). In addition, stem cell factor (SCF) hair will have grown for about 7 years. They have
from the dermal papilla (39,40) is essential for a much shorter catagen phase (1–2 weeks) and a
the proliferation, differentiation, and melanin telogen phase lasting several months. This means
production by follicular melanocytes expressing that the majority of normal scalp follicles are in
its receptor c-kit (40,41). anagen (80–85%), with the rest either in catagen
Once a hair reaches its full length, a short involu- (2%) or in telogen (10–15%), though this varies
tion phase, catagen, occurs. During this phase where with the time of the year for people living in
cell division and pigmentation stops, extensive temperate zones (see Seasonal changes in human
apoptosis occurs, and the dermal papilla shrinks; hair growth). The anagen phase in other body
the hair becomes fully keratinized with a swollen regions is substantially shorter; on the arms, legs,
“club” end and moves up in the skin with the and thighs it is about 3 to 4 months (45). Anagen
regressed dermal papilla, stopping near the arrector length generally determines hair length; long
pili muscle insertion. After a period of rest, telogen, scalp hairs are produced by follicles with anagen
the dermal papilla cells and associated keratinocyte periods of over 2 years, while short finger hairs
stem cells reactivate and the cycle begins again; only grow for around 2 months (45). The rate
another anagen phase develops a new lower follicle of hair growth varies much less over the body
318
Androgens and hair growth
usually being close to 0.3–0.4 mm per day (45,46). levels are negatively correlated with hair loss
This means that to change the amount of hair in rhesus macaque monkeys (56). In contrast,
produced for clinical reasons the main target is to thyroid hormones in rodents advance anagen
alter the length of anagen either by decreasing it while thyroidectomy or propylthiouracil delays it
for hirsutism or by increasing it for alopecia. (17,50). How these circulating hormones interact
is still unclear, but the main drivers in seasonal
coat changes are light, melatonin, and prolactin.
Hormonal factors affecting
mammalian hair growth Seasonal changes in human hair growth
Mammalian hair follicles, including human Seasonal alterations are much less obvious in human
follicles, are under hormonal regulation due to the beings, where follicle cycles are not usually
importance of coordinating alterations in insula- synchronized after the first year, other than in
tive and color properties of a mammal’s coat to groups of three follicles called Demeijère trios
the environment or its visibility to changes in (45). Regular annual cycles in human scalp (3–5)
sexual development. This is of life-threatening and beard and other body hair growth (3) were
importance to many mammals as too thin or only recognized relatively recently. Scalp hair
incorrectly colored hair could mean death from showed a single annual cycle with over 90% of
cold or predation. follicles in anagen in the spring, falling to around
80% in autumn in 14 healthy Caucasian men
aged 18–39 in Sheffield, UK (latitude 53.4°N); the
Hormonal coordination of seasonal changes
number of hairs shed in the autumn also more
in animals
than doubled (3). Similar increased autumnal
Seasonal changes usually occur twice a year in hair shedding has been reported in New York
many mammals living in temperate or polar women (4) and French men (5). Since scalp hair
regions with coordinated waves of growth and usually grows for at least 2–3 years and often
moulting to produce thick, warm winter coats longer (45), detection of an annual cycle indicates
and shorter summer pelage. These are linked to a strong response to seasonal hormonal changes
day-length and, to a lesser extent, temperature, such by any follicles able to react, presumably those in
as seasonal breeding activity (17,47). Nutrient later stages of the hair anagen phase.
availability can also affect hair type because of the Androgen-dependent body hair also showed
high metabolic requirements of hair production annual changes in men (3). Winter beard and
(48). Studies in many species show that long thigh hair growth rate were low, but increased
daylight hours initiate short periods of daily significantly in the summer (see (1)). French men
melatonin secretion by the pineal and summer coat showed similar summer peaks in semen volume,
development, while short day-length increases sperm count and mobility (57) suggesting androgen-
melatonin secretion and stimulates a longer, related effects, while higher summer testosterone
warmer pelage (47,49 reviewed in 1,17). The pineal levels with lower winter values were also reported
gland acts as a neuroendocrine transducer in European men (58,59) and pubertal boys (60).
converting nerve impulses stimulated by daylight Although testosterone changes probably alter
to reduced secretion of melatonin, normally beard and thigh hair growth, they seem less likely
secreted during the dark. Melatonin signals are to regulate scalp follicles as women also show
generally translated to the follicle via the hypo- seasonal changes. Annual fluctuations of thyroid
thalamus–pituitary route; prolactin particularly, hormones, with peaks of thyroxine (T3) in September
but also growth hormone and IGF-1 are impli- and free triiodothyronine (T4) in October (61),
cated at the follicle level (reviewed in 1). could also influence scalp growth, but hypothy-
Other hormones implicated in regulating roidism is normally associated with hair loss (62).
mammalian hair growth cycles include the sex Thigh follicles also showed biannual changes in
steroids, estradiol and testosterone, and the the numbers of hairs actually growing, reaching
adrenal steroids (1,17); these delay anagen in rats 80% in May and November, but falling to around
(17,50). Topical application of 17β-oestradiol to 60% in March and August (3). This pattern is
mice skin inhibits hair growth and accelerates similar to the spring and autumn moults of many
catagen, while antiestrogens promote early anagen temperate mammals and our seasonal study
(51–54). Testosterone also delays seasonal hair population definitely exhibited seasonal behavior
growth in badgers (55), while urinary cortisol despite indoor occupations (3); these cycles are
319
Randall
320
Androgens and hair growth
the chin in boys and hirsute women, spreading with androgen metabolism or receptors (reviewed
gradually over the face and neck (10). Similar (1)). Interestingly, women with polycystic ovaries
gradual progression occurs elsewhere taking and their brothers with early balding show links to
many years to show the full response like on a the steroid metabolism gene, CYP17 (90). A recent
man’s chest (19) or balding (20,79); terminal hairs study of androgenetic alopecia families suggests a
may only appear on the ear canal in the fifties new susceptibility gene on chromosome locus
(49). Interestingly, these slow changes resemble 3q26 (91).
the late androgen-dependent responses in the
prostate-causing prostatic benign hypertrophy
and carcinoma (81). Beard and axillary hair How do androgens carry out these
growth show another paradox; after their pubertal changes?
growth spurt, beard growth remains high, while
axillary hair growth decreases rapidly in both
General mechanism of action of androgens
sexes (19).
Steroid hormones diffuse through cell membranes
to act on target cells by binding to specific intrac-
Why do follicles respond so differently?
ellular receptors. These hormone-receptor complexes
These contrasts must be due to intrinsic differences undergo conformational changes, exposing DNA
in gene expression within follicles at different sites, binding sites, and bind to specific DNA hormone
since all receive the same circulating hormones response elements (HRE) often in combination
and use the same receptors. A follicle’s retention of with accessory (coactivating) proteins, promoting
its original androgen response when transplanted, expression of specific, hormone-regulated genes.
the basis of cosmetic hair transplants, confirms Androgen action is more complex than other
this (82). Presumably, this genetic programming steroids (92). The main male androgen, testosterone,
occurs during embryonic patterning processes. The binds receptors in some tissues, for example,
molecular mechanisms involved in the develop- skeletal muscle; in others, including secondary
ment of different follicle types are not clear, but sexual tissues like prostate, testosterone is meta-
secreted signaling factors (such as Eda, sonic bolized intracellularly by 5α-reductase to more potent
hedgehog, Wnt) and various growth factor families 5α-dihydrotestosterone (DHT), which binds more
(like the BMPs), nuclear factors (including various strongly to the androgen receptor (see FIGS 4 and
homeobox genes), and others such as Hairless 5) (93).
and Tabby, plus transmembrane and extracellular
matrix molecules are all implicated (83,84).
The mechanism of androgen action in hair
Human follicles require androgens to initiate
follicles
these marked changes. However, if adult men are
castrated, although beard growth falls (19) and Androgen-dependent follicles all require androgen
balding halts (85), neither returns to prepubertal receptors to respond (“Endocrine control of human
levels, indicating that androgens have altered hair growth”), but the need for 5α-reductase varies
some gene expression permanently or that the with body region. Men with 5α-reductase type 2
lower androgen levels provided by the adrenals deficiency only produce female patterns of pubic
can maintain a partial effect. Increased summer and axillary hair growth (94) (FIG. 1), indicating
beard growth (3), probably due to raised andro- that DHT is necessary for male-specific follicles
gens (Seasonal changes in human hair growth), like beard, while testosterone can stimulate the
and inhibition of hirsutism (86) or regrowth stim- axilla and pubic triangle in both sexes. Why
ulation in androgenetic alopecia (87,88) by drugs some follicles need DHT and others testosterone
interfering with androgen action confirms that to stimulate the same cell biological changes
androgens are also needed to maintain follicular is unclear; presumably, the cells use different
responses. intracellular coactivating proteins to act with the
Genetics also appears important (reviewed in receptor. Since 5α-reductase type 2 deficient men
1). Heavy beard growth (19) and balding (75) run do not show alopecia and the 5α-reductase type 2
in families and Caucasians generally exhibit inhibitor, finasteride, can restore hair growth (87),
more hair than Japanese (19) and more baldness 5α-reductase type 2 also seems important for
than Africans (89). Several genes have been inves- androgen-dependent balding. Skin contains many
tigated for association with androgen-sensitive enzymes that can metabolize weak androgens,
hair disorders with some links with those involved like dehydroepiandrosterone, to more powerful
321
Randall
322
Androgens and hair growth
follicles and prostate; and androgens acting on because of hair’s necessity for mammalian survival
embryonic prostate epithelium via the mesenchyme and/or sheath cells may respond directly to androgens
(81). This model now has strong experimental support. to facilitate alterations in sheath, or dermal papilla,
Androgen receptors are found in the dermal size to form a differently sized follicle.
papilla and cultured dermal papilla cells derived Investigations into keratins in the hair medulla
from androgen-sensitive follicles including beard, (only seen in the middle of large human hairs)
balding scalp, and deer manes (99–103). Cells from found a specialized keratin, hHa7, in beard, pubic,
androgen-sensitive sites contain higher levels of and axillary hair (109). Beard medulla cells showed
specific, saturable androgen receptors than androgen- coexpression of keratin hHa7 and the androgen
insensitive ones (99,101,102). Importantly, beard, receptor. Since the hHa7 gene promoter also
but not pubic or nonbalding scalp, dermal papilla contained sequences with high homology to the
cells metabolize testosterone to DHT in vitro (104– androgen response element (ARE), keratin hHa7
106), reflecting hair growth in 5α-reductase defi- expression may be androgen-regulated. However,
ciency; 5α-reductase type 2 gene expression also no stimulation occurred when the promoter was
supports this (103). transfected into prostate cells and keratin hHa7
However, some recent observations suggest with the same promoter is also expressed in
minor modifications. It is now clear that the der- androgen-insensitive body hairs of chimpanzees
mal sheath has other roles as well as isolating the making the significance unclear. Nevertheless, the
follicle; it can form a new dermal papilla and current model needs modification to include
stimulate follicle development (107). Cultured possible specific, direct action of androgens on
dermal sheath cells from beard follicles contain lower dermal sheath and medulla cells.
similar levels of androgen receptors to dermal
papilla cells (personal observations) and balding
The alteration of signaling molecules in the hair
dermal sheath express 5α-reductase type 2 mRNA
follicle by androgens
(108), indicating that the dermal sheath can
respond to androgens without the dermal papilla The last aspect of androgen action involves the
acting as an intermediary. The sheath may be a alteration of paracrine signaling factors produced by
reserve to replace a lost dermal papilla’s key roles dermal papilla cells. Although paracrine signaling
323
Randall
in developing and cycling follicles is currently a This all supports the model (FIG. 6) and shows that
major research focus, there are few practical animal the paradoxical androgen effects in vivo are reflected
models for studying androgens (110) because of in vitro, strengthening the use of cultured dermal
their special effects on human follicles. Cultured papilla cells as an in vitro model system.
dermal papilla cells from follicles with different Identifying the factors androgens alter could
sensitivities to androgens offer a useful, though lead to novel treatments for hair disorders. So far,
difficult to work with model in which to study only insulin-like growth factor (IGF-1), a potent
androgen effects (reviewed in 1). They secrete both mitogen, is identified as secreted by beard cells under
extracellular matrix (111) and soluble proteina- androgens in vitro (100). Beard cells also secrete
ceous factors that stimulate growth in other dermal more SCF than nonbalding scalp cells (118), while
papilla cells and various epithelial cells (98,112– balding cells produce less (119). Since SCF plays
114). Soluble factors from human cells can cross important roles in hair pigmentation (reviewed in
species affecting rodent cell growth in vitro and in 119), the dermal papilla probably provides local
vivo (115), paralleling the ability of human dermal SCF for follicular melanocytes. Androgens in vivo
papillae to induce hair growth in vivo in athymic appear to alter scf expression by facial dermal
mice (116). papilla cells to change melanocyte activity thus
Importantly, testosterone in vitro increases the altering hair color (119). Recently, DNA microarray
ability of beard cells to promote increased growth methods also revealed that three genes, sfrp-2,
of other beard dermal papilla cells and kerati- mn1, and atp1β1, were expressed at significantly
nocytes (112–114) but decreased that of androge- higher levels in beard than normal scalp cells, but
netic alopecia dermal papilla cells from both no changes were detected due to androgen in vitro
men (114) and stump-tailed macaques (117). This (120). Despite difficulties in culturing androgenetic
implies that an autocrine mechanism is involved; alopecia dermal papilla cells (121), androgens
androgen-mediated changes do involve alterations inhibit their expression of protease nexin-1, a potent
in dermal papilla cell numbers as well as the amount inhibitor of serine proteases, which regulate
of extracellular matrix (96). A need to modify the cellular growth and differentiation in many tissues
autocrine production of growth factors could (122). Androgens also stimulate their production of
contribute to the slow androgenic response that transforming growth factor-β (TGF-β) and TGF-β2
often takes many years to reach full effect (19). (123,124) and dickkopf 1(DKK1) (125). TGF-β is a
324
Androgens and hair growth
strong candidate for an inhibitor of keratinocyte biology, particularly androgen action, should lead
activity in alopecia (reviewed in 1), although TGF-β2 to new ways to treat hair disorders.
and TNF-α were actually slightly reduced in bald-
ing cells in a limited DNA macroarray analysis
(126). Thus, studying dermal papilla cells implicates
several factors already: IGF-1 in enlargement; SCF References
in altered pigmentation; and nexin-1, TGF-β, and
1. Randall VA. Hormonal regulation of hair follicles exhibits a
DKK1 in miniaturization. Alterations in several biological paradox. Semin Cell Dev Biol 2007: 18: 274 –285.
factors are probably necessary to precisely control 2. Jansen VAA, van Baalen M. Altruism through beard chro-
the major cell biological rearrangements required modynamics. Nature 2006: 440: 663–666.
when follicles change size. 3. Randall VA, Ebling EJG. Seasonal changes in human hair
growth. Br J Dermatol 1991: 124: 146–151.
4. Orentreich N. Scalp hair replacement in men. In: Montagna
W, Dobson RL, eds, Advances in biology of skin. Vol. 9: Hair
Summary and conclusions growth. Oxford, UK: Pergamon Press, 1969: 99–108.
5. Courtois M, Loussouarn G, Howseau S, et al. Periodicity in
In summary, changes in hair growth promoted by the growth and shedding of hair. Br J Dermatol 1996: 134:
47–54.
androgens often have strong negative effects on
6. Goodhart CB. The evolutionary significance of human hair
an individual’s quality of life because human hair patterns and skin coloring. Adv Sci 1960: 17: 53–58.
plays such important roles in human communica- 7. Bradfield RB. Protein deprivation: comparative response
tion. This is particularly true in hirsutism, that is, of hair roots, serum protein and urinary nitrogen. Am J Clin
excessive hair growth in women in the characteristic Nutrit 1971: 24: 405–410.
8. Reynolds EL. The appearance of adult patterns of body hair
male pattern, the subject of this issue. Although
in man. Ann N Y Acad Sci 1951: 53: 576–584.
many methods are available to remove excess 9. Marshall WA, Tanner JM. Variations in pattern of pubertal
hair as described in this issue (Physical Means of change in girls. Arch Dis Child 1969: 44: 291–303.
Treating Hirsutism) or drugs that help to modify 10. Marshall WA, Tanner JM. Variations in the pattern of
the excess growth (127,128 (in this issue, Medical pubertal changes in boys. Arch Dis Child 1970: 45: 13 –23.
11. West PM, Packer C. Sexual selection, temperature and the
Treatment of Hirsutism)), most treatments must
lion’s mane. Science 2002: 297: 1339–1343.
be applied continually to counteract the constant 12. Girman CJ, Rhodes T, Lilly FRW, et al. Effects of self-
supply of hormones. New therapeutic development perceived hair loss in a community sample of men. Dermatol
is hampered because we do not fully understand 1998: 197: 223–229.
how androgens cause their different effects on hair 13. Randall VA. Is alopecia areata an autoimmune disease?
Lancet 2001: 358: 1922–1924.
follicles depending on the body site. However, our
14. Randall VA. Physiology and pathophysiology of androgenetic
current knowledge has already led to the use of alopecia. In: Degroot LJ, Jameson JL, eds. Endocrinology,
antiandrogens, such as cyproterone acetate and 5th ed. Section XIV Burger H G, editor. Male reproduction.
spironolactone, and 5α-reductase inhibitors, like Philadelphia, PA: W B Saunders Co., 2005: 3295–3309.
finasteride, for hirsutism. 15. Dry FW. The coat of the mouse (Mus musculus). J Genet
1926: 16: 32– 35 .
Our increased awareness that androgen signals
16. Kligman AG. The human hair cycle. J Invest Dermatol 1959:
are received by the hair follicle dermal papilla and 33: 307–316.
translated to the hair follicle by paracrine signals, 17. Ebling FG, Hale PA, Randall VA. Hormones and hair
like growth factors, opens future avenues for novel growth. In: Goldsmith LA, ed. Biochemistry and physiology
therapeutic approaches. Recently, successful clinical of the skin, 2nd ed. Oxford, UK: Clarendon Press, 1991:
660–690.
response to the 5α-reductase inhibitor, finasteride,
18. Flux JEC. Colour change of mountain hares (Lepus timidus
was related to increased dermal papilla expression scotius) in north-east Scotland. Zoology 1970: 162: 345 –
of IGF-1 (129), confirming the importance of dermal 358.
papilla-produced paracrine factors. Basic research 19. Hamilton JB. Age, sex and genetic factors in the regulation
has also recently identified potassium channels of hair growth in man. A comparison of Caucasian and
Japanese populations. In: Montagna W, Ellis RA, eds, The
in hair follicles which can be opened by minoxidil
biology of hair growth. New York: Academic Press, 1958,
or other potassium channel openers, enabling a 399–433.
mechanism for minoxidil’s previously unexplained 20. Hamilton JB. Patterned loss of hair in man; types and
action in stimulating hair growth despite its use incidence. Ann NY Acad Sci 1951: 53: 708–728.
for balding for over 20 years (130,131). Inhibiting/ 21. Randall VA. Androgens and human hair growth. Clin Endo-
crinol 1994: 40: 439–457.
closing these channels could also potentially treat
22. Randall VA. Androgens and hair: a biological paradox. In:
hirsutism as potassium channel blockers, e.g., Nieschlag E, Behre HM, eds, Testosterone: action, deficiency,
tolbutamide, inhibit cultured hair follicles in vitro substitution, 3rd ed. Berlin, Germany, and Cambridge, UK:
(130,131). Greater understanding of hair follicle University Press, 2004: 207– 231.
325
Randall
23. Montagna W, Van Scott EJ. The anatomy of the hair follicle. 43. Milner Y, Sudnik J, Filippi M, Kizoulis M, Kashgarian M,
In: Montagna W, Ellis RA, eds, The biology of hair growth. Stenn K. Exogen, shedding phase of the hair growth cycle:
New York: Academic Press, 1958: 39– 64. characterization of a mouse model. J Invest Dermatol 2002:
24. Chase HB. Growth of the hair. Physiol Rev 1954: 34: 113– 119: 639–644.
126. 44. Van Neste D, Leroy T, Conil S. Exogen hair characterization
25. Nutbrown M, Randall VA. Differences between connective in human scalp. Skin Res Technol 2007: 13: 436–443.
tissue-epithelial junctions in human skin and the anagen 45. Saitoh M, Sakamoto M. Human hair cycle. J Invest Derma-
hair follicle. J Invest Dermatol 1995: 104: 90–94. tol 1970: 54: 65–81.
26. Jahoda CA, Horne KA, Oliver RF. Induction of hair growth 46. Van Neste D. Thickness, medullation and growth rate of
by implantation of cultured dermal papilla cells. Nature female scalp hair are subject to significant variation
1984: 311: 560 –562. according to pigmentation and scalp location during
27. Reynolds AJ, Jahoda CAB. Cultured human and rat tooth ageing. Eur J Dermatol 2004: 14: 28–32.
papilla cells induce hair follicle regeneration and fibre 47. Lincoln GA, Richardson M. Photo-neuroendocrine control
growth. Differentiation 2004: 72: 566–575. of seasonal cycles in body weight, pelage growth and
28. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reproduction: lessons from the HPD sheep model. Comp
reside in the bulge area of pilosebaceous unit: implications Biochem Physiol Part C 1998: 119: 283–294.
for follicular stem cells, hair cycle, and skin carcinogenesis. 48. Johnson E. Seasonal changes in the skin of mammals.
Cell 1990: 61: 1329 –1337. Symp Zool Soc Land 1977: 39: 373–304.
29. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J 49. Santiago-Moreno J, Lopez-Sebastian A, del Campo A,
Invest Dermatol 2006: 126: 1459–1468. Gonzalez-Bulnes A, Picazo R, Gomez-Brunet A. Effect of
30. Nishimura EK, Jordan SA, Oshima H, et al. Dominant role constant-release melatonin implants and prolonged
of the niche in melanocyte stem-cell fate determination. exposure to a long day photoperiod on prolactin secretion
Nature 2002: 416: 854– 860. and hair growth in mouflon (Ovis gmelini musimon).
31. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano Domest Anim Endocrinol 2004: 26: 303–314.
AM, Jahoda CA. Trans-gender induction of hair follicles. 50. Johnson E. Qualitative studies of hair growth in the albino
Nature 1999: 402: 33–34. rat II. The effects of sex hormones. J Endocrinol 1958: 16:
32. Rudman SM, Philpott MP, Thomas GA, Kealey T. The role 351–359.
of IGF-I in human skin and its appendages: morphogen as 51. Oh H-S, Smart RC. An estrogen receptor pathway regulates
well as mitogen? J Invest Dermatol 1997: 109: 770–777. the telogen-anagen hair follicle transition and influences
33. Danilenko DM, Ring BD, Yanagihara D, et al. Keratinocyte epidermal cell proliferation. Proc Natl Acad Sci 1996: 93:
growth factor is an important endogenous mediator of hair 12525–12530.
follicle growth, development, and differentiation. Normal- 52. Smart RC, Oh HS, Chanda S, Robinette CL. Effects of 17-beta-
ization of the nu/nu follicular differentiation defect and estradiol and ICI 182 780 on hair growth in various strains
amelioration of chemotherapy-induced alopecia. Am J of mice. J Investig Dermatol Symp Proc 1999: 4: 285–289.
Pathol 1995: 147: 145–154. 53. Chanda S, Robinette CL, Couse JF, Smart RC. 17beta-estradiol
34. Lindner G, Menrad A, Gherardi E, et al. Involvement of and ICI-182780 regulate the hair follicle cycle in mice
hepatocyte growth factor/scatter factor and met receptor through an estrogen receptor-alpha pathway. Am J Physiol
signaling in hair follicle morphogenesis and cycling. FASEB Endocrinol Metab 2000: 278: E202–E210.
J 2000: 14: 319 –332. 54. Ohnemus U, Uenalan M, Conrad F, et al. Hair cycle
35. Botchkarev VA, Botchkareva NV, Nakamura M, et al. Noggin control by estrogens: catagen induction via ER{alpha} is
is required for induction of hair follicle growth phase in checked by ER{beta} signalling. Endocrinology 2005: 145:
postnatal skin. FASEB J 2001: 15: 2205–2214. 1214 –1225.
36. Botchkarev VA, Kishimoto J. Molecular control of epithelial- 55. Maurel D, Coutant C, Boissin J. Thyroid and gonadal regu-
mesenchymal interactions during hair follicle cycling. J Invest lation of hair growth during the seasonal moult in the male
Dermatol Symp Proc 2003: 8: 46–55. European badger, Meles meles L. Gen Comp Endocrinol
37. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol 1987: 65: 317–327.
Rev 2001: 449 –494. 56. Steinmetz HW, Kaumanns W, Dix I, Heistermann M,
38. Randall VA, Botchkareva NV. The biology of hair growth. In: Fox M, Kaup F-J. Coat condition, housing condition and
Ahluwalia GA, ed. Cosmetic applications of laser and light measurement of faecal cortisol metabolites – a non-invasive
based systems. Ch 1. William Andrew Inc., USA 2009: 3–35. study about alopecia in captive rhesus macaques (Macaca
39. Hibberts NA, Messenger AG, Randall VA. Dermal papilla mulatta). J Med Primatol 2006: 35: 3–11.
cells derived from beard hair follicles secrete more stem 57. Reinberg A, Smolensky MH, Hallek M, Smith KD, Stein-
cell factor (SCF) in culture than scalp cells or dermal berger E. Annual variation in semen characteristics and
fibroblasts. Biochem Biophys Res Commun 1996: 222: plasma hormone levels in men undergoing vasectomy.
401–405. Fertil Steril 1988: 49: 309–315.
40. Randall VA, Jenner T, Hibberts N, De Oliveira I, Vafaee T. 58. Reinberg A, Lagoguey M, Chauffourinier JM, Cesselin F.
Stem cell factor/c-kit signalling in normal and androgenetic Circannual and circadian rhythms in plasma testosterone
alopecia. J Endocrinol 2008: 197: 1–14. in five healthy young Parisian males. Acta Endocrinol 1975:
41. Botchkareva NV, Khlgatian M, Longley BJ, Botchkarev VA, 80: 732–743.
Gilchrest BA. SCF/c-kit signaling is required for cyclic 59. Smals AGH, Kloppenberg PWC, Benrad THJ. Circannual
regeneration of the hair pigmentation unit. FASEB J 2001: cycle in plasma testosterone levels in man. J Clin Endo-
15: 645 –658. crinol Metabol 1976: 42: 979–982.
42. Stenn K, Parimoo S, Prouty S. Growth of the hair follicle: a 60. Bellastella A, Criscuoco T, Mango A, Perrone L, Sawisi AJ,
cycling and regenerating biological system. In: Chuong Faggiano M. Circannual rhythms of LH, FSH, testosterone,
CM, ed. Molecular basis of epithelial appendage morpho- prolactin and cortisol during puberty. Clin Endocrinol
genesis. Austin, TX: RG Landes Co., 1998: 111–130. 1983: 19: 453–459.
326
Androgens and hair growth
61. Pasquali R, Baraldi G, Casimirri F, et al. Seasonal variations of 83. Lin CM, Jiang TX, Widelitz RB, Chuong CM. Molecular
total and free thyroid hormones in healthy men: a chronobi- signaling in feather morphogenesis. Curr Opin Cell Biol
ological study. Acta Endocimol (Copenh) 1984: 107: 42–48. 2006: 18: 730–741.
62. Eckert J, Church RE, Ebling FJ, Munro DS. Hair loss in 84. Mou C, Jackson B, Schneider P, Overbeek PA, Headon DJ.
women. Br J Dermatol 1967: 79: 543–548. Generation of the primary hair follicle pattern. Proc Natl
63. Wehr TA. Effects of seasonal changes in daylength on human Acad Sci USA 2006: 103: 9075 –9080.
neuroendocrine function. Horm Res 1998: 49: 118–124. 85. Hamilton JB. Effect of castration in adolescent and young
64. Yoneyama S, Hashimoto S, Honma K. Seasonal changes of adult males upon further changes in the proportions of
human circadian rhythms in Antarctica. Am J Physiol 1999: bare and hairy scalp. J Clin Endocrinol Metabol 1960: 20:
227: R1091–R1097. 1309–1318.
65. Wehr TA, Duncan WC Jr, Sher L, et al. A circadian signal of 86. Martin KA, Chang RJ. Ehrmann DA, et al. Evaluation and
change of season in patients with seasonal affective disorder. treatment of hirsutism in premenopausal women: an endo-
Arch Gen Psychiatry 2001: 58: 1115–1116. crine society clinical practice guideline. J Clin Endocrinol
66. Rushton HD. Commentary: decreased serum ferritin and Metab 2008: 93: 1105–1120.
alopecia in women. J Invest Dermatol 2003: 121: xvii–xviii. 87. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in
67. Jackson D, Church RE, Ebling FJG. Hair diameter in female the treatment of men with androgenetic alopecia. J Am
baldness. Br J Derm 1972: 87: 361– 367. Acad Dermatol 1998: 39: 578–589.
68. Lynfield YL. Effect of pregnancy on the human hair cycle. J 88. Olsen EA, Hordinsky M, Whiting D, et al. Dutasteride
Invest Dermatol 1960: 35: 323–327. Alopecia Research Team. The importance of dual 5alpha-
69. Fiotzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R. reductase inhibition in the treatment of male pattern hair
Human scalp hair follicles are both a target and a source of loss: results of a randomized placebo-controlled study of
prolactin, which serves as an autocrine and/or paracrine dutasteride versus finasteride. J Am Acad Dermatol 2006:
promoter of apoptosis-driven hair follicle regression. Am J 55: 1014–1023.
Pathol 2006: 168: 748–756. 89. Setty LR. Hair patterns of the scalp of white and negro
70. Thornton MJ, Nelson LD, Taylor AH, Birch MP, Laing I, males. Am J Phys Anthrop 1970: 33: 49–55.
Messenger AG. The modulation of aromatase and estrogen 90. Carey AH, Chan KL, Short F, White D, Williamson R,
receptor alpha in cultured human dermal papilla cells by Franks S. Evidence for a single gene effect causing poly-
dexamethasone: a novel mechanism for selective action of cystic ovaries and male pattern baldness. Clin Endocrinol
estrogen via estrogen receptor beta? J Invest Dermatol 1993: 38: 653–658.
2006: 126: 2010–2018. 91. Hillmer AM, Flaquer A, Hanneken S, et al. Genome-wide
71. Conrad F, Ohnemus U, Bodo E, Bettermann A, Paus R. scan and fine-mapping linkage study of androgenetic
Estrogens and human scalp hair growth-still more questions alopecia reveals a locus on chromosome 3q26. Am J Hum
than answers. J Invest Dermatol 2004: 122: 840–842. Genet 2008: 82: 737–743.
72. Ohnemus U, Uenalan M, Inzunza J, Gustafsson J-Å, Paus R. 92. Handelsman DJ. Androgen action and pharmacologic
The hair follicle as an estrogen target and source. Endocr uses. In: DeGroot LJ, Jameson JL, eds, Endocrinology, 5th
Rev 2006: 27: 677–706. ed. Section XIV Burger H G, editor. Male reproduction.
73. Winter JSD, Faiman C. Pituitary-gonadal relations in male Philadelphia, PA: W B Saunders Co., 2005: 3121–3138.
children and adolescents. Paed Res 1972: 6: 125 – 135. 93. Randall VA. The role of 5α-reductase in health and disease.
74. Winter JSD, Faiman C. Pituitary-gonadal relations in female In: Sheppard M, Stewart P, eds. Hormones, enzymes and
children and adolescents. Paed Res 1973: 7: 948–953. receptors. Baillières Clin Endo Metabol 1994: 8: 405 – 431.
75. Chieffi M. Effect of testosterone administration on the 94. Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2
beard growth of elderly males. J Gerontol 1949: 4: 200–204. deficiency. Endocr Rev 1993: 14: 577–593.
76. Hamilton JB. Effect of castration in adolescent and young adult 95. Van Scott EJ, Ekel TM. Geometric relationships between
males upon further changes in the proportions of bare and the matrix of the hair bulb and its dermal papilla in
hairy scalp. J Clin Endocrinol Metabol 1960: 20: 1309–1318. normal and alopecic scalp. J Invest Dermatol 1958: 31:
77. McPhaul MJ. Mutations that alter androgen function; 281–287.
androgen insensitivity and related disorders. In: Degroot 96. Elliot K, Stephenson TJ, Messenger AG. Differences in hair
LJ, Jameson JL, eds. Endocrinology, 5th ed. Section XIV follicle dermal papilla volume are due to extracellular
Burger H G, editor. Male reproduction. Philadelphia, PA: W matrix Volume and cell number. Implications for the con-
B Saunders Co., 2005: 3139–3157. trol of hair follicle size and androgen responses. J Invest
78. Blok GJ, de Boer H, Gooren LJ, van der Veen EA. Growth Dermatol 1999: 113: 873–877.
hormone substitution in adult growth hormone-deficient men 97. Sawers RA, Randall VA, Iqbal MJ. Studies on the clinical
augments androgen effects on the skin. Clin Endocrinol and endocrine aspects of antiandrogens. In: Jeffcoate JL,
1997: 47: 29–36. ed. Androgens and antiandrogen therapy. Current topics
79. Norwood OTT. Male pattern baldness. Classification and in endocrinology, Vol. 1. Chichester, UK: John Wiley, 1982:
incidence. South Med J 1975: 68: 1359–1370. 145–168.
80. Ludwig E. Classification of the types of androgenic alopecia 98. Randall VA, Thornton MJ, Hamada K, et al. Androgens
(common baldness) arising in the female sex. Br J Dermatol and the hair follicle: cultured human dermal papilla cells
1977: 97: 249– 256. as a model system. Ann NY Acad Sci 1991: 642: 355 – 375.
81. Hayward S, Donjacour AA, Bhowmick NA, et al. Endocri- 99. Randall VA, Thornton MJ, Messenger AG. Cultured der-
nology of the prostate and benign prostatic hyperplasia. In: mal papilla cells from androgen-dependent human hair
Degroot LJ, Jameson JLB, eds, Endocrinology, 5th ed. Section follicles (e.g. beard) contain more androgen receptors than
XIV Burger H G, editor. Male reproduction. Philadelphia, those from non-balding areas of scalp. J Endocrinol 1992:
PA: W B Saunders Co., 2005: 3311– 3324. 3: 141–147.
82. Orentreich N, Durr NP. Biology of scalp hair growth. Clin 100. Itami S, Kurata S, Takayasu S. Androgen induction of
Plast Surg 1982: 9: 197–205. follicular epithelial cell growth is mediated via insulin-like
327
Randall
growth factor I from dermal papilla cells. Biochem Bio- 116. Jahoda CA, Oliver RF, Reynolds AJ, et al. Trans-species
phys Res Commun 1995: 212: 988– 994. hair growth induction by human hair follicle dermal
101. Hibberts NA, Howell AE, Randall VA. Dermal papilla cells papillae. Exp Dermatol 2001: 10: 229–237.
from human balding scalp hair follicles contain higher 117. Obana N, Chang C, Uno H. Inhibition of hair growth by
levels of androgen receptors than those from non-balding testosterone in the presence of dermal papilla cells from
scalp. J Endocrinol 1998: 156: 59– 65. the frontal bald scalp of the post-pubertal stump-tailed
102. Thornton MJ, Hibberts NA, Street T, Brinklow BR, Loudon macaque. Endocrinol 1997: 138: 356–361.
AS, Randall VA. Androgen receptors are only present in 118. Hibberts NA, Messenger AG, Randall VA. Dermal papilla
mesenchyme-derived dermal papilla cells of red deer (Cer- cells derived from beard hair follicles secrete more stem
vus elaphus) neck follicles when raised androgens induce a cell factor (SCF) in culture than scalp cells or dermal
mane in the breeding season. J Endocrinol 2001: 168: fibroblasts. Biochem Biophys Res Commun 1996: 222:
401–408. 401–405.
103. Ando Y, Yamaguchi Y, Hamada K, Yoshikawa K, Itami S. 119. Randall VA, Jenner TJ, Hibberts NA, De Oliveira IO, Vafaee T.
Expression of mRNA for androgen receptor, 5α-reductase Stem cell factor/c-Kit signalling in normal and androgenetic
and 17β-hydroxysteroid dehydrogenase in human dermal alopecia hair follicles. J Endocrinol 2008: 197: 11–23.
papilla cells. Br J Derm 1999: 141: 840– 845. 120. Rutberg SE, Kolpak ML, Gourley JA, Tan G, Henry JP,
104. Itami S, Kurata S, Takayasu S. 5α-reductase activity in Shander S. Differences in expression of specific biomark-
cultured human dermal papilla cells from beard com- ers distinguish human beard from scalp dermal papilla
pared with reticular dermal fibroblasts. J Invest Derma- cells. J Invest Dermatol 2006: 126: 2583–2595.
tol 1990: 94: 150–152. 121. Randall VA, Hibberts NA, Hamada K. A comparison of the
105. Thornton MJ, Liang I, Hamada K, Messenger AG, Randall culture and growth of dermal papilla cells derived from
VA. Differences in testosterone metabolism by beard and normal and balding (androgenetic alopecia) scalp. Br J
scalp hair follicle dermal papilla cells. Clin Endocrinol Dermatol 1996: 134: 437–444.
1993: 39: 633 –639. 122. Sonada T, Asada Y, Kurata S, Takayasu S. The mRNA for
106. Hamada K, Thornton MJ, Liang I, Messenger AG, Randall protease nexin-1 is expressed in human dermal papilla
VA. Pubic and axillary dermal papilla cells do not produce cells and its level is affected by androgen. J Invest Derma-
5α-dihydrotestosterone in culture. J Invest Dermatol tol 1999: 113: 308–313.
1996: 106: 1017–1022. 123. Inui S, Fukuzato Y, Nakajima F, Yoshikawa K, Itami S.
107. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Androgen-inducible TGFbeta1 from balding dermal
Christiano AM, Jahoda CAB. Trans-gender induction of papilla cells inhibits epithelial cell growth: a clue to
hair follicles. Nature 1999: 402: 33– 34. understand paradoxical effects of androgen on human
108. Asada Y, Sonoda T, Ojiro M, et al. 5α-reductase type hair growth. FASEB J 2002: 16: 1967–1969.
2 is constitutively expressed in the dermal papilla and 124. Hibino T, Nishiyama T. Role of TGF-b2 in the human hair
connective tissue sheath of the hair follicle in vivo but cycle. J Dermatol Sci 2004: 35: 9–18.
not during culture in vitro. J Clin Endocr Metab 2001: 86: 125. Kwack MH, Sung YK, Chung EJ, et al. Dihydrotestoster-
2875 –2880. one-inducible dickkopf 1 from balding dermal papilla
109. Jave-Suarez LF, Langbein L, Winter H, Praetzel S, Rogers cells causes apoptosis in follicular keratinocytes. J Invest
MA, Schweizer J. Androgen regulation of the human hair Dermatol 2008: 128: 262–269.
follicle: the type 1 hair keratin hHa7 is a direct target gene 126. Midorikawa T, Chikazawa T, Yoshino T, Takada K, Arase
in trichocytes. J Invest Dermatol 2004: 122: 555–564. S. Different gene expression profile observed in dermal
110. Randall VA, Sundberg JP, Philpott MP. Animal and in vitro papilla cells related to androgenic alopecia by DNA
models for the study of hair follicles. J Invest Derm Symp macroarray analysis. J Dermatol Sci 2004: 36: 25–32.
Proc 2003: 8: 39 – 45. 127. Azziz R. The evaluation and management of hirsutism.
111. Messenger AG, Elliott K, Temple A, Randall VA. Expression Obstet Gynecol 2003: 101: 995–1007.
of basement membrane proteins and interstital collagens 128. Ross EK, Shapiro J. Management of hair loss. Dermatol
in dermal papillae of human hair follicles. J Invest Der- Clin 2005: 23: 227–243.
matol 1991: 96: 93–97. 129. Tang L, Bernardo O, Bolduc C, Lui H, Madani S, Shapiro J.
112. Thornton MJ, Hamada K, Messenger AG, Randall VA. The expression of insulin-like growth factor 1 in follicular
Beard, but not scalp, dermal papilla cells secrete auto- dermal papillae correlates with therapeutic efficacy of
crine growth factors in response to testosterone in vitro. J finasteride in androgenetic alopecia. J Am Acad Dermatol
Invest Dermatol 1998: 111: 727–732. 2003: 49: 229–233.
113. Itami S, Kurata S, Sonada T, Takayasu S. Interactions 130. Davies GC, Thornton MJ, Jenner TJ, et al. Novel and
between dermal papilla cells and follicular epithelial cells established potassium channel openers stimulate hair
in vitro: effect of androgen. Br J Derm 1995: 132: 527–532. growth in vitro: implications for their modes of action in
114. Hibberts NA, Randall VA. Testosterone inhibits the capac- hair follicles. J Invest Dermatol 2005: 124: 686–694.
ity of cultured cells from human balding scalp dermal 131. Shorter K, Farjo NP, Picksley SM, Randall VA. The human
papilla cells to produce keratinocyte mitogenic factors. hair follicle contains two forms of ATP-sensitive potas-
In: Van Neste DV, Randall VA, eds. Hair research for the sium channels, only one of which is sensitive to minoxi-
next millennium. Amsterdam: Elsevier, 1996: 303–306. dil. FASEB J 2008: 22: 1725–1736.
115. Hamada K, Randall VA. Inhibitory autocrine factors 132. Randall VA. Androgens: the main regulator of human hair
produced by themesenchyme-derived hair follicle dermal growth. In: Camacho FM, Randall VA, Price VH, eds. Hair
papilla may be a key to male pattern baldness. Br J and its disorders: biology, pathology and management.
Dermatol 2006: 154: 609– 618. London, UK: Martin Dunitz, 2000: 69–82.
328